Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 5, 2008 - Issue 6
Submit an article Journal homepage
300
Views
6
CrossRef citations to date
0
Altmetric
CLINICAL REVIEW

Obstructive Lung Disease Models: What Is Valid?

Jill M. Ferdinands Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
&
David M. Mannino Division of Pulmonary and Critical Care Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA
Pages 382-393 | Published online: 02 Jul 2009

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Issa J. Dahabreh, John B. Wong & Thomas A. Trikalinos. (2017) Validation and calibration of structural models that combine information from multiple sources. Expert Review of Pharmacoeconomics & Outcomes Research 17:1, pages 27-37.
Read now
Christian Becker, Astrid Langer & Reiner Leidl. (2011) The quality of three decision-analytic diabetes models: a systematic health economic assessment. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 751-762.
Read now
Viroj Wiwanitkit. (2009) Finding a new drug and vaccine for emerging swine flu: What is the concept?. Biologics: Targets and Therapy 3, pages 377-383.
Read now

Articles from other publishers (3)

Emma Tan, Ruud Boessen, David Fishwick, Rinke Klein Entink, Tim Meijster, Anjoeka Pronk, Birgit van Duuren-Stuurman & Nick Warren. (2015) A microsimulation model for the development and progression of chronic obstructive pulmonary disease. Respiratory Medicine 109:12, pages 1521-1531.
Crossref
Hossein Haji Ali Afzali, Jodi Gray & Jonathan Karnon. (2013) Model Performance Evaluation (Validation and Calibration) in Model-based Studies of Therapeutic Interventions for Cardiovascular Diseases. Applied Health Economics and Health Policy 11:2, pages 85-93.
Crossref
Douglas W. Mapel & Melissa H. Roberts. (2012) New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses. PharmacoEconomics 30:10, pages 869-885.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.